Schlesinger Group, a leading international data collection and research services company, has added Schlesinger Clinical Research, a clinical data collection services provider to its suite of brands following its substantial growth in the discipline.

Schlesinger Clinical Research addresses an unmet need in the market by encompassing all data collection aspects necessary for clinical research under one roof. The company boasts thirty proprietary sites and expert team with principal investigation experience, as well as CITI-certification in Good Clinical Practice and Human Subjects Protection to ensure adherence to study protocols.

Schlesinger Clinical Research offers a single point of contact to oversee the recruitment and consistent application of clinical study research protocols nationwide. The company specializes in Rx-to-OTC and Non-Rx product research that often involves IRB approval and FDA submissions. Schlesinger Clinical Research has worked with many of the world’s largest universities, CROs, CPG, pharma, and insight companies.

As an approved government vendor and fully FDA CFR Part-11 compliant, the company is currently supporting electronic nicotine delivery system (ENDS) manufacturers who are seeking a partner to streamline their clinical testing to meet the September 9th submission deadline for the FDA Premarket Tobacco-Product Applications (PMTA).

The addition of Schlesinger Clinical Research adds high quality regulated research to Schlesinger Group’s portfolio of capabilities, and underscore its position as the world's most comprehensive data collection and research services provider.

Commenting on the news, Rob Ramirez, EVP, Schlesinger Group, said, “This offering stands to revolutionize clinical research outcomes for clients through streamlining the research process by bringing site selection, subject enrolment, and study execution expertise under one partner.”

SCHLESINGER GROUP
Schlesinger Group is a leading data collection company offering a broad range of qualitative and quantitative solutions worldwide and delivering high-quality recruitment and research services for any methodology. Its recent acquisition of 20|20 Research has brought a unique suite of in-house online qualitative research platforms to its offering. Schlesinger Group has research offices in the US, UK, France, Spain, Germany, and India. Schlesinger’s reach coverage is global, and the company leverages automation and the high API panel connectivity capabilities of recently acquired Market Cube.

Main Executives
Steve Schlesinger, CEO & Mike Sullivan, President

Schlesinger Clinical Research Web Page
https://www.schlesingergroup.com/en/solutions/clinical-research/

Schlesinger Group Company Brands
Schlesinger Qualitative Market Cube (Acquired 2020)
Schlesinger Quantitative 20|20 Research (Acquired 2020)
Schlesinger Europe                                         Focus Pointe Global (Acquired 2109 - now Schlesinger Group)
Schlesinger Clinical Research Vigie Pharma (Acquired 2015)
Schlesinger Transcription Services IVP Research labs
Schlesinger Trial & Jury Consulting Everyone Talks
Advisors by Schlesinger

Get content that matters, written by top insights industry experts, delivered right to your inbox.

67k+ subscribers

Get the latest updates from top market research, insights, and analytics experts delivered weekly to your inbox

Your guide for all things market research, Insights, and analytics